RADIATION & RISK
Bulletin of the National Radiation and Epidemiological Registry
since 1992
About the Journal : 2026 : vol. 35, No. 2 : 40 years after the Chernobyl nuclear power plant accident. Development and application of retrospective dosimetry technologies for uncontrolled radiation exposure of the population and subsequent conversion of these technologies for use in oncoradiology: a brief analytical review

40 years after the Chernobyl nuclear power plant accident. Development and application of retrospective dosimetry technologies for uncontrolled radiation exposure of the population and subsequent conversion of these technologies for use in oncoradiology: a brief analytical review

«Radiation and Risk», 2026, vol. 35, No. 2, pp.207-226

DOI: 10.21870/0131-3878-2026-35-2-207-226

Authors

Stepanenko V.F. – Head of Lab., D. Sc., Biol., Prof. Contacts: 4 Korolev str., Obninsk, Kaluga region, Russia, 249035; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Ivanov S.A. – Director, Corr. Member of RAS, MD, Prof. of RUDN University Dep.
Ivanov V.K. – Scien. Advisor of NRER, Chairman of RSCRP, Corr. Member of RAS, D. Sc., Tech., Prof.
Bogacheva V.V. – Lead. Res., C. Sc., Biol.
Petukhov A.D. – Sen. Res., C. Sc., Biol
Dorokhov A.V. – Engineer-Res.
Kiseleva M.V. – Head of Dep., MD, Prof.
Biryukov V.A. – Head of Dep., C. Sc., Med., Assoc. Prof.
Korotkov V.A. – Head of Dep., C. Sc., Med.
Kucherov V.V. – Head of Dep., C. Sc., Med.
Petrosyan A.P. – Phys.-Radiologist, C. Sc., Med.
Sigov M.A. – Head of Dep.
Krylov V.V. – Head of Dep., Director of INM, MD
Shurinov A.Yu. – Dep. Director of INM, C. Sc., Med.
Petrosyan K.M. – Radiologist
Kochetova T.Yu. – Radiologist
Vlasova O.P. – Lead. Res., C. Sc., Biol.
Tishchenko V.K. – Head of Lab., D. Sc., Biol.
Ivannikov A.I. – Lead. Res., C. Sc., Phys.-Math.
Khailov A.M. – Sen. Res., C. Sc., Biol. A. Tsyb MRRC.
Kaprin A.D. – Gen. Director, Director of P. Hertsen MORI, Head of RUDN University Dep., Academ. of RAS, MD, Prof.
Shegay P.V. – Dep. Gen. Director, MD
Zharova E.P. – Scien. Secretary, C. Sc., Biol. NMRRC.
Zhumadilov K.Sh. – Head of Dep., Prof., PhD.
Sarsenova S.M. – Doc. Stud. L.N. Gumilyov ENU, Kazakhstan.
Hoshi M. – Prof., PhD. Hiroshima University, Japan.
1 A. Tsyb MRRC, Obninsk
2 NMRRC, Obninsk
3 Peoples' Friendship University of Russia named after Patrice Lumumba, Moscow
4 P. Hertsen MORI, Moscow
5 L.N. Gumilyov Eurasian National University, Astana, Kazakhstan
6 Hiroshima University, Hiroshima, Japan

Abstract

The article briefly describes: a) the role and place of computational and instrumental methods of retrospective dosimetry, developed and implemented with the participation of specialists from the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, in assessing the consequences of the Chernobyl accident for the population living in the territories of the Russian Federation contaminated with radionuclides; b) the subsequent development of retrospective dosimetry technologies in application to oncoradiology – for in vivo dosimetry in brachytherapy of malignant tumors of various localizations and for dosimetry of internal irradiation of tumor formations and organs at risk during radionuclide therapy. This brief analytical review demonstrates the conversion of retrospective dosimetry methods developed in response to the extreme challenges of a large-scale radiological accident into instrumental and computational technologies for dosimetry of foci and organs at risk in patients, intended for systematic use in oncoradiology – with the aim of providing dosimetric guarantees of the quality and safety of brachytherapy and radionuclide therapy methods for malignant neoplasms.

Key words
Chernobyl nuclear power plant accident, methods of retrospective dosimetry of the population, retrospective dosimetry of external irradiation, retrospective dosimetry of internal irradiation, radiation epidemiology, radiation safety, oncoradiology, radiology, nuclear medicine, in vivo dosimetry in brachytherapy, dosimetry of patients in radionuclide therapy.

References

1. Information about the accident at the Chernobyl nuclear power plant and its consequences, prepared for the IAEA. Atomnaya energiya – Atomic Energy, 1986, vol. 61, no. 5. pp. 301-320. (In Russian).

2. Il’in L.A., Balonov M.I., Buldakov L.A., Bur’iak V.N., Gordeev K.I., Dementiev S.I., Kondrusev A.I., Liaginskaia A.M., Matyukhin V.A., Ramzaev P.V., Savkin M.N., Konstantinov Yu.O., Linge I.I., Likhtarev I.A., Tsyb A.F., Stepanenko V.F., Ivanov V.K. Environmental features and medical-biological consequences of the accident at the Chernobyl nuclear power plant. Meditsinskaya radiologiya – Medical Radiology, 1989, vol. 34, no. 11, pp. 58-81. (In Russian).

3. Medical radiological consequences of Chernobyl: prognosis and evidence after 30 years. Eds.: V.K. Ivanov, A.D. Kaprin. Moscow, GEOS, 2015. 450 p. (In Russian).

4. Ivanov V.K., Tsyb A.F. Medical radiological consequences of Chernobyl for the population of Russia: assessment of radiation risks. Moscow, Meditsina, 2002. 392 p. (In Russian).

5. Ivanov V., Tsyb A., Ivanov S., Pokrovsky S. Medical radiological consequences of the Chernobyl catastrophe in Russia: estimation of radiation risks. St. Petersburg, Nauka, 2004. 388 p. (In Russian).

6. Radiation epidemiology of diseases of the human blood circulation system after radiation accidents. Ed.: V.K. Ivanov. Obninsk, A. Tsyb MRRC, 2016. 168 p. (In Russian).

7. De Cort M., Dubois G., Fridman Sh.D., Germenchuk M.G., Izrael Yu.A., Janssens A., Jones A.R., Kelly G.N., Kvasnikova E.V., Matveenko I.I., Nazarov I.M., Pokumeiko Yu.M., Sitak V.A., Stukin E.D., Tabachny L.Ya., Tsaturov Yu.S., Avdyushin S.I. Atlas of caesium deposition on Europe after the Chernobyl accident. Luxembourg, Office for Official Publications of European Communities, 2008. Available at: https://op.europa.eu/en/publication-detail/-/publication/110b15f7-4df8-49a0-856f-be8f681ae9f (Accessed 23.06.2025).

8. Assessment of doses to the public from ingested radionuclides. Safety Reports Series No. 14. Vienna, IAEA, 1999. 87 p. Available at: https://www-pub.iaea.org/MTCD/Publications/PDF/P067_scr.pdf (Accessed 20.04.2026).

9. Direct methods for measuring radionuclides in the human body. Safety Series No. 114. Vienna, IAEA, 1996. 110 p. Available at: https://gnssn.iaea.org/Superseded%20Safety%20Standards/Safety_Se-ries_114_1996.pdf (Accessed 23.03.2026).

10. Use of electron paramagnetic resonance dosimetry with tooth enamel for retrospective dose assessment. Report of a coordinated research project. IAEA-TECDOC-1331. Vienna, IAEA, 2002. 57 p. Available at: https://www-pub.iaea.org/MTCD/Publications/PDF/te_1331_web.pdf (Accessed 25.03.2026).

11. Bailiff I. K., Stepanenko V. Retrospective dosimetry and dose reconstruction. Brussels-Luxembourg, Direc-torate-General for Research and Innovation, European Commission, 1996. 120 p. Available at: https://op.eu-ropa.eu/en/publication-detail/-/publication/13fe2c27-5c12-4bf9-ad66-537572fffdc1 (Accessed 23.03.2026).

12. Proceedings of the International Conference on biodosimetry and 5th International Symposium on ESR do-simetry and applications. Eds.: M.F. Desrosiers, D.F. Regulla, A.F. Skinner, V. Skvortsov, U.A. Fill, V. Ste-panenko. New York, Pergamon, 2000. 373 p.

13. Radiological protection – Minimum criteria for electron paramagnetic resonance (EPR) spectroscopy for retrospective dosimetry of ionizing radiation (ISO 13304-2:2020). Geneva, ISO, 2020. Available at: https://standards.iteh.ai/catalog/standards/cen/f72eade6-a759-4d79-8277-0fdef6be55cd/en-iso-13304-2-2022#:~:text=EN%20ISO%2013304%2D2:2022,d)%20the%20measurement%20apparatus (Accessed 24.03.2026).

14. Ivanov V.K., Maksioutov M.A., Tumanov K.A., Kochergina E.V., Vlasov O.K., Chekin S.Yu., Gorski A.I., Korelo A.M., Shchukina N.V., Zelenskaya N.S., Lashkova O.E., Ivanov S.A., Kaprin A.D. 35-year experi-ence in the functioning of the National Radiation and Epidemiological Registry as a State information system for monitoring the radiological consequences of the Chernobyl accident. Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 1. pp. 7-39. (In Russian).

15. Vlasov O.K., Shchukina N.V., Chekin S.Yu., Tumanov K.A. Methods for dosimetry support of radiation-epidemiological studies carried out at NRER. Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 1, pp. 40-57. (In Russian).

16. Ivanov V.K., Kashcheev V.V., Chekin S.Yu., Maksioutov M.A., Tumanov K.A., Kochergina E.V., Lash-kova O.E., Menyajlo A.N., Karpenko S.V., Lovachev S.S., Korelo A.M., Vlasov O.K., Shchukina N.V., Ivanov S.A., Kaprin A.D. Assessment of radiation risks of malignant neoplasms among the population of Russian regions contaminated with radionuclides as a result of the Chernobyl accident. Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 1, pp. 110-130. (In Russian).

17. Stepanenko V.F., Kaprin A.D., Ivanov S.A., Shegay P.V., Kolyzhenkov T.V., Bogacheva V.V., Iaskova E.K., Petukhov A.D., Karyakin O.B., Kiseleva M.V., Krikunova L.I., Borysheva N.B., Biryukov V.A., Rukhadze G.A., Kucherov V.V., Korotkov V.A., Ivannikov A.I., Khailov A.M., Zharova E.P., Zhumadilov K.Sh., Endo S., Hoshi M. 35 years after the Chernobyl NPP accident: methods of retrospective dosimetry in assessing of the consequences of large-scale uncontrolled radiation exposures, their subsequent development and application in oncoradiology (experience of A. Tsyb MRRC). Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 2, pp. 7-24. (In Russian).

18. Stepanenko V.F. Dosimetric monitoring and retrospective dosimetry of the population in the early and remote periods after the Chernobyl accident: the experience of the MRRC. Medical radiological consequences of Chernobyl: prognosis and evidence after 30 years. Eds.: V.K. Ivanov, A.D. Kaprin. Moscow, GEOS, 2015, pp. 10-53. (In Russian).

19. Bailiff I.K., Stepanenko V.F., Göksu H.Y., Bøtter-Jensen L., Brodski L., Chumak V., Correcher V., Delgado A., Golikov V., Jungner H., Khamidova L.G., Kolizshenkov T.V., Likhtarev I., Meckbach R., Petrov S.A., Sholom S. Comparison of retrospective liminescnence dosimetry with computational modeling in two highly con-taminated settlements downwind of the Chernobyl NPP. Health Phys., 2004. vol. 86, no. 1, pp. 25-41.

20. Bailiff I.K., Stepanenko V.F., Göksu H.Y., Bøtter-Jensen L., Correcher V., Delgado A., Jungner H., Khamidova L.G., Kolizshenkov T.V., Meckbach R., Petin D.V., Orlov M.Y., Petrov S.A. Retrospective luminescence dosimetry: development of approaches to application in populated areas downwind of the Cher-nobyl NPP. Health Phys., 2005, vol. 89, no. 3, pp. 233-246.

21. Stepanenko V.F., Endo S., Kaprin A.D., Ivanov S.A., Kajimoto T., Tanaka K., Kolyzhenkov T.V., Petu-khov A.D., Akhmedova U.A., Bogacheva V.V., Korotkov V.A., Hoshi M. An experience of instrumental estimation of cumulative external doses using single grain luminescence retrospective dosimetry method with quartz containing samples from Fukushima prefecture, Japan. Radiatsiya i risk – Radiation and Risk, 2018, vol. 27, no. 3, pp. 79-90. (In Russian).

22. Dedov V.I., Dedov I.I., Stepanenko V.F. Radiation endocrinology. Moscow, Medicine, 1993. 208 p. (In Russian).

23. Results of dosimetric and medical examination of the population of several districts of the Kaluga region located in the zone of radioactive fallout following the Chernobyl accident. Ed.: A.F. Tsyb. Obninsk, MRRC of RAMS, 1986. 345 p. (In Russian).

24. Stepanenko V.F., Yaskova E.K., Orlov M.Yu., Kryukova I.G., Matveenko E.G., Tsyb A.F. Internal irradiation of the thyroid gland among residents of the Kaluga region according to data from mass instrumental measure-ments of 131I in May 1986. Atomnaya energiya – Atomic Energy, 2008. vol. 105, no. 2, pp. 97-103. (In Russian).

25. Tsyb A.F., Stepanenko V.F., Matveenko E.G., Pitkevich V.A., Ispenkov E.A., Omel'chenko V.N., Leshakov S.Yu. Structure and levels of thyroid irradiation in population of contaminated areas of Kaluga region. Radiatsiya i risk – Radiation and Risk, 1994, vol. 4, pp. 129-135. (In Russian).

26. Stepanenko V.F., Gavrilin Yu.I., Khrouch V.T., Shinkarev S.M., Hoshi M., Iaskova E.K., Kondrashov A.E., Petin D.V., Moskovko L.I., Takada J., Skvortsov V.G. , Orlov M.Yu., Ivannikov A.I., Ermakova N.M., Tsyb A.F., Proshin A.D., Rivkind N.B. Re-evaluation of thyroid doses in Russia after the Chernobyl accident. Chernobyl: message for the 21st Century, International Congress Series. Amsterdam, Elsevier Science, 2002, vol. 1234, pp. 321-328.

27. Stepanenko F.F., Voillequé P.G., Gavrilin Yu.I., Khrouch V.T., Shinkarev S.M., Orlov M.Y., Kondrashov A.E., Petin D.V., Iaskova E.K., Tsyb A.F. Estimating individual thyroid doses for a case-control study of childhood thyroid cancer in Bryansk Oblast, Russia. Radiat. Prot. Dosimetry, 2004, vol. 108, no. 2, pp. 143-60.

28. Stepanenko V., Skvortsov V., Tsyb A., Ivannikov A., Kondrashov A., Tikunov D., Iaskova E., Shakhtarin V., Petin D., Parshkov E., Chernichenko L., Snykov V., Orlov M., Gavrihn Yu., Khrousch V., Shinkarev S. Thyroid and whole-body dose reconstruction in Russia following the Chernobyl accident: review of progress and results. Radiat. Prot. Dosim., 1998, vol. 77, no. 1/2, pp. 101-106.

29. Davis S., Stepanenko V., Rivkind N., Kopecky K.J., Voilleque P., Shakhtarin V., Parshkov E., Kulikov S., Lushnikov E., Abrosimov A., Troshin V., Romanova G., Doroschenko V., Proshin A., Tsyb A. Risk of thyroid cancer in the Bryansk oblast of the Russian Federation after the Chernobyl power station accident. Radiat. Res., 2004, vol. 162, no. 3, pp. 241-248.

30. Kopecky K.J., Stepanenko V., Rivkind N., Voillequé P., Onstad L., Shakhtarin V., Parshkov E., Kulikov S., Lushnikov E., Abrosimov A., Troshin V., Romanova G., Doroschenko V., Proshin A., Tsyb A., Davis S. Childhood thyroid cancer, radiation dose from Chernobyl, and dose uncertainties in Bryansk Oblast, Russia: a population-based case-control study. Radiat. Res., 2006, vol. 166, no. 2, pp. 367-74.

31. Stepanenko V.F., Orlov M.Yu., Petin D.V., Tikunov D.D., Borysheva N.B., Ivannikov A.I., Skvortsov V.G., Yaskova E.K., Kolyzhenkov T.V., Kryukova I.G., Moskovko L.I., Tsyb A.F., Proshin A.B., Rivkind N.B. Retrospective individual dosimetry in a populated area with high radioactive contamination. Atomnaya ener-giya – Atomic Energy, 2003, vol. 95, no. 1, pp. 60-67. (In Russian).

32. Rivkind N., Stepanenko V., Belukha I., Guenthoer J., Kopecky K.J., Kulikov S. Kurnosova I., Onstad L., Porter P., Shklovskiy-Kordi N., Troshin V., Voilleque P., Davis S. Female breast cancer risk in Bryansk oblast, Russia, following prolonged low dose rate exposure to radiation from the Chernobyl power station accident. Int. J. Epidem., 2020, vol. 49, no. 2, pp. 448-456.

33. Davis S., Day R.W., Kopecky K.J., Mahoney M.C., McCarthy P.L., Michalek A.M., Moysich K.B., Onstad L.E., Stepanenko V.F., Voilleque P.G., Chegerova T., Falkner K., Kulikov S., Maslova E., Ostapenko V., Rivkind N., Shevchuk V., Tsyb A.F. Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl accident: results from an international collaborative population-based case-control study. Int. J. Epidem., 2006, vol. 35, no. 2, pp. 386-396.

34. Rumyantsev P.O., Saenko V.A., Ilyin A.A., Stepanenko V.F., Rumyantseva U.V., Abrosimov A.Y., Lush-nikov E.F., Rogounovitch T.I., Shibata Y., Mitsutake N., Tsyb A.F., Yamashita S. Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer. J. Clin. Endocrinol. Metab., 2011, vol. 96, no. 2, pp. 385-393.

35. Kaprin A.D., Ivanov S.A., Stepanenko V.F., Borysheva N.B. In vivo dosimetry in determining the spatial intracavitary distribution of the absorbed dose during brachytherapy with a 192Ir source. Issledovaniya i praktika v meditsine – Research and Practical Medicine Journal, 2019, vol. 6, no. 1, pp. 131. (In Russian).

36. Stepanenko V.F., Kaprin A.D., Ivanov S.A., Shegay P.V., Biryukov V.A., Krikunova L.I., Borysheva N.B., Zharova E.P., Kulieva G., Kolyzhenkov T.V., Bogacheva V.V., Petukhov A.D., Korotkov V.A. Current state of "in vivo" dosimetry using luminescent microdosimeters: innovative technologies and materials. Radi-ation and Organism: Proceedings of the final scientific and practical conference. Obninsk, A. Tsyb MRRC, 2019, pp. 155-157. (In Russian).

37. Stepanenko V.F., Biryukov V.A., Kaprin A.D., Galkin V.N., Ivanov S.A., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Ivannikov A.I., Borysheva N.B., Skvortsov V.G., Akhmedova U.A., Bo-gacheva V.V., Petukhov A.D., Yaskova E.K., Khailov A.M., Lepilina O.G., Sanin D.B., Korotkov V.A., Obukhov A.A., Anokhin Yu.N. Intracavitary offline "in vivo" dosimetry for high dose-rate prostate brachy-therapy with 192Ir: development of technology and first results of its application. Radiatsiya i risk – Radiation and Risk, 2017, vol. 26, no. 2, pp. 72-82. (In Russian).

38. Stepanenko V.F., Biryukov V.A., Kaprin A.D., Galkin V.N., Ivanov S.A., Borysheva N.B., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Obukhov A.A., Ivannikov A.I., Skvortsov V.G., Akhmedova U.A., Bogacheva V.V., Petukhov A.D., Yaskova E.K., Khailov A.M., Lepilina O.G., Sanin D.B., Korotkov V.A., Anokhin Yu.N. In vivo dosimetry at high dose rate brachytherpapy for prostate cancer using 192Ir: comparison of dose distribution between planned and measured doses with intracavitary placement of autonomous luminescence microdosimeters. Radiatsiya i risk – Radiation and Risk, 2018, vol. 27, no. 1, pp. 66-76. (In Russian).

39. Petukhov A.D., Bogacheva V.V., Stepanenko V.F., Biryukov V.A., Korotkov V.A., Zharova E.P., Minaeva N.G., Ivanov S.A., Shegai P.V., Kaprin A.D. Use the phenomenon of thermo stimulated luminescence in sea salt microcrystals for intracavitary «in vivo» dosimetry at 192Ir brachytherapy for prostate cancer: an assessment of the potential. Radiatsiya i risk – Radiation and Risk, 2024, vol. 33, no. 3, pp. 46-54. (In Russian).

40. Zharova E.P., Stepanenko V.F., Kiseleva M.V., Bogacheva V.V., Aminov G.G., Kolyzhenkov T.V., Petu-khov A.D., Zharikova I.A., Demyanovich A.V., Borysheva N.B., Ivanov S.A., Kaprin A.D. In vivo dosimetry with luminescent microdosimeters in 192Ir brachytherapy of breast cancer: development of technology and clinical testing. Radiatsiya i risk – Radiation and Risk, 2020, vol. 29, no. 2, pp. 67-77. (In Russian).

41. Bogacheva V.V., Stepanenko V.F., Krikunova L.I., Petukhov A.D., Kulieva G.Z., Kolyshenkov T.V., Zha-rova E.P., Korotkov V.A., Ivanov S.A., Shegay P.V., Kaprin A.D. Intracavitary «in vivo» dosimetry at the high dose rate brachytherapy in oncogynecology. Radiatsiya i risk – Radiation and Risk, 2022, vol. 31, no. 4, pp. 119-131. (In Russian).

42. Radiotherapy Risk Profile WHO/IER/PSP/2008.12. Geneva, WHO, 2008. 51 p. Available at: https://cdn.who.int/media/docs/default-source/patient-safety/radiotherapy/090715-who-radiotherapy_risk_profile.pdf (Accessed 02.01.2026).

43. Lessons learned from accidental exposures in radiotherapy. Safety Report Series No. 17. Vienna, IAEA, 2000. 96 p. Available at: https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1084_web.pdf (Accessed 02.01.2026).

44. ICRP, 2005. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97. Ann. ICRP, 2005, vol. 35, no. 2, pp. 1-52. Available at: https://journals.sagepub.com/doi/pdf/10.1177/ANIB_35_2 (Accessed 02.01.2026).

45. Brachytherapy. Eds.: A.D. Kaprin, Yu.S. Mardinsky. Obninsk, A. Tsyb MRRC, 2017. 245 p. (In Russian).

46. Bolch W.E., Eckerman K.F., Sgouros G., Thomas R. MIRD pamphlet No. 21: a generalized schema for ra-diopharmaceutical dosimetry-standardization of nomenclature. J. Nucl. Med., 2009, vol. 50, no. 3, pp. 477-484.

47. Stepanenko V.F., Petriev V.M., Kaprin A.D., Ivanov S.A., Shegay P.V., Bogacheva V.V., Kolyzhenkov T.V., Petukhov A.D., Krylov V.V., Kucherov V.V., Sigov M.A., Vlasova O.P., Petrosyan A.P., Petrosyan K.M., Spichenkova O.N., Ivannikov A.I., Khailov A.M., Korotkov V.A., Zharova E.P., Eremeev M.R. Personalized dosimetry of internal exposure to foci and organs at risk of patients: development and implementation of a me-thodological basis for dosimetric support of clinical trials of therapeutic radiopharmaceuticals. Radiatsiya i risk – Radiation and Risk, 2023, vol. 32, no. 1, p.156-167. (In Russian).

48. Stepanenko V.F., Bogacheva V.V., Dorokhov A.V., Petukhov A.D., Kucherov V.V., Krylov V.V., Petro-sian A.P., Kochetova T.Yu., Shurinov A.Yu., Ivanov S.A., Shegay P.V., Kaprin A.D. Calculation of spatial distributions of absorbed energy of ionizing radiation in biological tissue for sources of different shapes and sizes at internal irradiation by alpha-particles, electrons and photons with various energies: a unified approach for use in nuclear medicine. Radiatsiya i risk – Radiation and Risk, 2025, vol. 34, no. 1, pp. 82-94. (In Russian).

49. Stepanenko V.F., Bogacheva V.V., Petukhov A.D., Dorokhov A.V., Kucherov V.V., Petrosyan A.P., Sigov M.A., Kochetova T.Yu., Krylov V.V., Shurinov A.Yu., Vlasova O.P., Tishchenko V.K., Biryukov V.A., Korotkov V.A., Zharova E.P., Shegay P.V., Ivanov S.A., Kaprin A.D. Results of research work on the State Programme "System of personalized dosimetric planning of radionuclide therapy". Radiation and Organism: Proceedings of the final scientific and practical conference. Obninsk, A. Tsyb MRRC, 2025, pp. 46-47. (In Russian).

50. Stepanenko V.F., Bogacheva V.V., Petukhov A.D., Dorokhov A.V., Kochetova T.Yu., Sigov M.A., Spichenkova O.N., Vlasova O.P., Krylov V.V., Smolyarchuk M.Ya., Shurinov A.Yu., Minaeva N.G., Ivanov S.A., Shegay P.V., Kaprin A.D. Dosimetric support for clinical trials of the alpha-emitting radiophar-maceutical 225Ac-PSMA-617 at radionuclide therapy of metastatic castration-resistant prostate cancer. Radiatsiya i risk – Radiation and Risk, 2025, vol. 34, no. 3, pp. 30-42. (In Russian).

51. Kucherov V.V., Petrosyan A.P., Vlasova O.P., Sigov M.A., Tishchenko V.K., Spichenkova O.N., Stepanenko V.F., Shegay P.V., Ivanov S.A., Kaprin A.D. Clinical study’s results of the safety of the radio-pharmaceutical labeled with 188Re during intraarterial radioembolization. Radiatsiya i risk – Radiation and Risk, 2024, vol. 33, no. 3, pp. 18-29. (In Russian).

52. Krylov V.V., Legkodimova N.S., Kochetova T.Yu., Petriev V.M., Sigov M.A., Tishchenko V.K., Pronin A.I., Shurinov A.Yu., Petrosyan K.M., Spichenkova O.N., Karyakin O.B., Biryukov V.A., Stepanenko V.F., Vlasova O.P., Shegay P.V., Ivanov S.A., Kaprin A.D. Radioligand therapy with 177Lu-DOTA-PSMA in me-tastatic castration-resistant prostate cancer. Pharmacokinetics, safety, antitumor efficacy. Luchevaya diag-nostika i terapiya – Diagnostic Radiology and Radiotherapy, 2022, vol. 13. no. 4, pp. 75-85. (In Russian).

53. Tishchenko V.K., Vlasova O.P., Ryzhikova T.P., Stepanenko V.F., Sigov M.A., Kucherov V.V., Bogacheva V.V., Spichenkova O.N., Petrosyan A.P., Petukhov A.D., Dorovatovsky S.A., Shegay P.V., Ivanov S.A., Kaprin A.D. Distribution of 188Re in the body of patients and the values of individual absorbed doses of internal irradiation during intra-arterial radioembolization with the radiopharmaceutical “MCA, 20-40 μm, 188Re”. Onkologiya. Zhurnal im. P.A. Gertsena – P.A. Hertzen Journal of Oncology, 2025, vol. 14, no. 5, pp. 47-53. (In Russian).

54. Petrosyan K.M., Krylov V.V., Lugovaya A.V., Vlasova O.P., Sigov M.A., Stepanenko V.F., Bogacheva V.V., Tishchenko V.K., Spichenkova O.N., Ivanov S.A., Kaprin A.D. Results of safety study of radiopharmaceu-tical drug preparation based on albumin microspheres of 5-10 μm diameter labeled with rhenium-188. Radiatsiya i risk – Radiation and Risk, 2025, vol. 34, no. 4, pp. 160-172. (In Russian).

55. Kochetova T.Yu., Krylov V.V., Stepanenko V.F., Musabaev I.E., Ivanov S.A., Kaprin A.D. Safety assess-ment of escalating activities of the RFLP 225Ac-PSMA-617 for the treatment of patients with metastatic castration-resistant prostate cancer progressing after standard therapies. Voprosy onkologii – Problems in Oncology, 2025, vol. 71, no. 5, pp. 1114-1151. (In Russian).

56. Radiation protection and safety in medical uses of ionizing radiation. IAEA Safety Standards Series No. SSG-46. Vienna, IAEA, 2018. 322 p. Available at: https://www-pub.iaea.org/MTCD/Publications/PDF/PUB1775_web.pdf (Accessed 12.01.2026).

57. ICRP, 2018. Radiological protection in therapy with radiopharmaceuticals. ICRP Publication 140. Ann. ICRP, 2019, vol. 48, no. 1, pp. 1-95.

58. Dosimetry-guided radiopharmaceutical therapy. ICRU Report 96. J. ICRU, 2021, vol. 21, no. 1, pp. 1-212.

59. Sources and effects of ionizing radiation: UNSCEAR 2000 Report to the General Assembly. Annex J. Expo-sures and effects of the Chernobyl accident. New York, United Nations, 2000. 109 p.

Full-text article (in Russian)